Listen to our latest Investing Matters Podcast episode 'Uncovering opportunities with investment trusts' with The AIC's Richard Stone here.

Less Ads, More Data, More Tools Register for FREE

BROKER RATINGS SUMMARY: JPMorgan Raises Auto Trader To Overweight

Thu, 18th Feb 2016 09:31

LONDON (Alliance News) - The following shares received analyst recommendations Thursday morning:
----------
FTSE 100
----------
EXANE BNP CUTS HAMMERSON TO 'NEUTRAL' ('OUTPERFORM') - TARGET 620 (680) PENCE
----------
JEFFERIES CUTS SPORTS DIRECT PRICE TARGET TO 550 (800) PENCE - 'BUY'
----------
JEFFERIES CUTS HIKMA PHARMACEUTICALS PRICE TARGET TO 2355 (2555) PENCE - 'BUY'
----------
DEUTSCHE BANK CUTS HSBC PRICE TARGET TO 500 (580) PENCE - 'HOLD'
----------
JPMORGAN RAISES ROLLS-ROYCE PRICE TARGET TO 690 (395) PENCE
----------
JPMORGAN RAISES ROLLS-ROYCE TO 'NEUTRAL' ('UNDERWEIGHT')
----------
HSBC RAISES ANGLO AMERICAN TO 'HOLD' ('REDUCE') - TARGET 520 (180) PENCE
----------
SOCGEN RAISES ANGLO AMERICAN PRICE TARGET TO 390 (250) PENCE - 'SELL'
----------
BERENBERG CUTS ASTRAZENECA PRICE TARGET TO 5200 (5300) PENCE - 'BUY'
----------
GOLDMAN CUTS CENTRICA PRICE TARGET TO 201 (205) PENCE - 'NEUTRAL'
----------
BERENBERG CUTS WOLSELEY PRICE TARGET TO 4100 (4200) PENCE - 'BUY'
----------
FTSE 250
----------
Shore Capital Upgrades Go-Ahead Group To Buy From Hold
----------
CITIGROUP RAISES FIDESSA GROUP PRICE TARGET TO 2100 (2050) PENCE - 'NEUTRAL'
----------
JPMORGAN CUTS BBA AVIATION PRICE TARGET TO 199 (201) PENCE - 'NEUTRAL'
----------
JPMORGAN RAISES AUTO TRADER GROUP TO 'OVERWEIGHT' ('NEUTRAL')
----------
HSBC CUTS TALK TALK TELECOM PRICE TARGET TO 225 (260) PENCE - 'HOLD'
----------
HSBC CUTS CWC PRICE TARGET TO 70 (81) PENCE - 'HOLD'
----------
MAIN MARKET AND AIM
----------
GOLDMAN CUTS DAILY MAIL PRICE TARGET TO 655 (678) PENCE - 'SELL'
----------
By Arvind Bhunjun; arvindbhunjun@alliancenews.com; @ArvindBhunjun

Copyright 2016 Alliance News Limited. All Rights Reserved.

Related Shares

More News
20 Jun 2024 10:56

TOP NEWS: AstraZeneca's Truqap gets OK from EU for breast cancer form

(Alliance News) - AstraZeneca PLC on Thursday said that the EU approved its prescription medicine Truqap, in combination with hormonal therapy Faslode...

18 Jun 2024 09:33

TOP NEWS: AstraZeneca disappointed by breast cancer drug trial results

(Alliance News) - AstraZeneca PLC on Tuesday said findings from a breast cancer drug trial showed that Truqap did not meet its primary endpoints.

18 Jun 2024 07:51

LONDON BRIEFING: Ashtead profit declines; Whitbread sales rise

(Alliance News) - London's FTSE 100 is called to open higher on Tuesday, taking confidence from a decent showing for US equities overnight, with infla...

18 Jun 2024 07:17

AstraZeneca trial fails to treat 'challenging' breast cancer

(Sharecast News) - AstraZeneca announced on Tuesday that the phase three 'CAPItello-290' trial for 'Truqap', or capivasertib, in combination with pacl...

17 Jun 2024 09:09

TOP NEWS: Astra's Imfinzi plus chemo approved for cancer form in US

(Alliance News) - AstraZeneca PLC on Monday said it secured a new US approval for cancer treatment Imfinzi, also known as durvalumab, hailing an "impo...

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.